[vc_row][vc_column][vc_video link=”https://youtu.be/38vjVsUtsQQ” title=”Learn about the PRESIDIO Clinical Trial of KZR-616 for the Treatment of Polymyositis and Dermatomyositis”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
About Kezar, KZR-616, and PRESIDIO
Dr. Mary Katherine (MK) Farmer, MD, Rheumatologist and Senior Medical Director at Kezar Life Sciences, joined us live on Rare Disease Day 2020 and introduced Kezar, KZR-616, and the PRESIDIO Clinical Study.
In this video, Dr. Farmer discusses the science behind KZR-616, an investigational treatment for autoimmune diseases, and provides an overview of PRESIDIO, a phase 2 study of KZR-616 in Polymyositis and Dermatomyositis which is currently enrolling in trial sites across the U.S.[/vc_column_text][vc_btn title=”Visit the PRESIDIO website” style=”flat” shape=”square” color=”primary” size=”lg” link=”url:https%3A%2F%2Fwww.kezarlifesciences.com%2FPRESIDIOstudy%2F%3Futm_source%3Dsponsors-2020%26utm_medium%3Ddisplay%26utm_campaign%3Dmyositislife|title:Visit%20the%20PRESIDIO%20study%20website|target:%20_blank|”][vc_btn title=”Download presentation slides” style=”flat” shape=”square” color=”primary” size=”lg” link=”url:https%3A%2F%2Funderstandingmyositis.org%2Fdocs%2Ftrials%2FKezar-Intro-to-KZR-616.pdf|title:PRESIDIO%20slide%20presentation|target:%20_blank|”][/vc_column][/vc_row][vc_row css=”.vc_custom_1583456697012{padding-top: 25px !important;padding-bottom: 20px !important;}”][vc_column][vc_column_text]
About Dr. MK Farmer, MD
She was diagnosed with dermatomyositis in 2003 during residency and left clinical practice in 2010 to pursue a career in clinical research with her strong foundation in autoimmune diseases. She has worked with most of the major pharmaceutical companies and has worked on several medications that have been approved for different diseases.
She came to Kezar Life Sciences in mid-2019 to take a once-in-a-lifetime opportunity to run the myositis development program.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
About Kezar Life Sciences
A sponsor of Myositis Support and Understanding (MSU)
Kezar is currently recruiting patients to participate in Phase 2 clinical trials. The diseases being studied in these trials are: lupus nephritis, dermatomyositis, polymyositis, autoimmune hemolytic anemia, and immune thrombocytopenia.[/vc_column_text][/vc_column][/vc_row]